US Patent Issued to AC Immune on Oct. 6 for "Antibodies binding to alpha-synuclein for therapy and diagnosis" (Swiss Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,223, issued on Oct. 6, was assigned to AC Immune SA (Lausanne, Switzerland).

"Antibodies binding to alpha-synuclein for therapy and diagnosis" was invented by Elpida Tsika (Lausanne, Switzerland), John Warner (Lausanne, Switzerland) and Jan Peter Henning Stohr (Lausanne, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel molecules that can be employed for the prevention, alleviation, treatment and/or diagnosis of diseases, disorders and abnormalities associated with alpha-synuclein (Alpha-synuclein, A-synuclein, aSynuclein, A-syn, Alpha-syn, aSyn, a-syn) aggregates, including, but not limited to, Lewy bo...